临床试验/ISRCTN77951167

ISRCTN77951167进行中（未招募）未知

Mild bleeding disorders caused by platelet defects: a non-randomised observational study

niversity of Birmingham0 个研究点目标入组 1,200 人开始时间: 2011年4月28日最近更新: 2024年4月29日

试验速览

阶段: 未知
状态: 进行中（未招募）
发起方: niversity of Birmingham
入组人数: 1,200

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

2013 Results article in http://www.ncbi.nlm.nih.gov/pubmed/23809206 results 2014 Results article in http://www.ncbi.nlm.nih.gov/pubmed/24408324 results 2014 Results article in http://www.ncbi.nlm.nih.gov/pubmed/24618131 results 2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25567036 results 2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25556537 results 2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26280575 results 2017 Results article in http://www.ncbi.nlm.nih.gov/pubmed/28762630 results

研究设计

研究类型: Observational

入排标准

性别: All

入选标准

•1. Patients, aged 0 ?- 85 years, either sex
•2. Diagnosed with a platelet disorder of unknown cause
•3. Willing to participate and able to provide informed consent

排除标准

•1. Patients taking drugs that are known to influence platelet function, including nonsteroidal anti-inflammatory drugs (NSAIDs) including COX-2 selective anti-inflammatory drugs), aspirin, clopidogrel, dipyridamole, warfarin or acenocoumarol within 7 days of enrolment
•2. Patients having undergone a major surgical procedure within 1 month of enrolment
•3. Patients with chronic renal failure requiring dialysis
•4. Patients with a platelet count outside the 100 000 to 450 000/µL range
•5. Patients with severe anaemia (haemoglobin < 8g/dl)

研究者

发起方

niversity of Birmingham

相似试验

进行中（未招募）

Italian Study for Congenital Platelet DisordersPlatelet Disorder

NCT06691581Fondazione Policlinico Universitario Agostino Gemelli IRCCS200

Platelet Activity in Vascular Surgery and Cardiovascular EventsPeripheral Artery DiseaseCritical Limb IschemiaCardiovascular Disease

NCT02106429NYU Langone Health246

Platelet function in 22q11.2 deletion syndrome

NL-OMON24347one60

Exploring bleeding risk and platelet function combined with multiple omics techniques in 22q11.2 deletion syndromeDiGeorge syndromeVelocardiofacial syndrome100355341008362410039628

NL-OMON55192Medisch Universitair Ziekenhuis Maastricht60

ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUSSystemic Scleroderma MeetingANCA VasculitisInflammatory MyositisGougerot-Sjögren SyndromeRheumatoid ArthritisSystemic Lupus Erythematosus

NCT06593041University Hospital, Strasbourg, France450